盐酸雷洛昔芬结构式
|
常用名 | 盐酸雷洛昔芬 | 英文名 | Raloxifene HCl |
|---|---|---|---|---|
| CAS号 | 82640-04-8 | 分子量 | 510.044 | |
| 密度 | 1.285g/cm3 | 沸点 | 728.2ºC at 760 mmHg | |
| 分子式 | C28H28ClNO4S | 熔点 | 143-147ºC | |
| MSDS | 中文版 美版 | 闪点 | 394.2ºC |
盐酸雷洛昔芬用途Raloxifene hydrochloride (LY156758 hydrochloride) 是第二代雌激素受体拮抗剂。 |
| 中文名 | 盐酸雷洛昔芬 |
|---|---|
| 英文名 | raloxifene hydrochloride |
| 中文别名 | [6-羟基-2-(4-羟苯基)苯并[b]噻酚-3-基]-[4-[2-(1-哌啶基)乙氧基]-苯基]-甲酮盐酸盐 | 雷洛西芬中间体 |
| 英文别名 | 更多 |
| 描述 | Raloxifene hydrochloride (LY156758 hydrochloride) 是第二代雌激素受体拮抗剂。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 密度 | 1.285g/cm3 |
|---|---|
| 沸点 | 728.2ºC at 760 mmHg |
| 熔点 | 143-147ºC |
| 分子式 | C28H28ClNO4S |
| 分子量 | 510.044 |
| 闪点 | 394.2ºC |
| 精确质量 | 509.142761 |
| PSA | 98.24000 |
| LogP | 6.81510 |
| 外观性状 | 淡黄色固体 |
| 折射率 | 1.654 |
| 储存条件 | -20°C Freezer |
| 水溶解性 | DMSO: 28 mg/mL, soluble |
| 盐酸雷洛昔芬上游产品 10 | |
|---|---|
| 盐酸雷洛昔芬下游产品 1 | |
|
Oxidative metabolic pathway of lenvatinib mediated by aldehyde oxidase.
Drug Metab. Dispos. 42(8) , 1326-33, (2014) Lenvatinib is a multityrosine kinase inhibitor that inhibits vascular endothelial growth factor receptors, and is being developed as an anticancer drug. P450s are involved in one of the elimination pa... |
|
|
Selective estrogen-receptor modulators suppress microglial activation and neuronal cell death via an estrogen receptor-dependent pathway.
J. Steroid Biochem. Mol. Biol. 145 , 85-93, (2015) Growing evidence shows that steroid hormones, especially 17β-estradiol (E2), protect neuronal cells by attenuating excess activation of microglia. However, the use of E2 in the clinic is controversial... |
|
|
Bioluminescent cell-based NAD(P)/NAD(P)H assays for rapid dinucleotide measurement and inhibitor screening.
Assay Drug Dev. Technol. 12(9-10) , 514-26, (2014) Abstract The central role of nicotinamide adenine dinucleotides in cellular energy metabolism and signaling makes them important nodes that link the metabolic state of cells with energy homeostasis an... |
| [6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl][4-(2-piperidin-1-ylethoxy)phenyl]methanone hydrochloride |
| [6-Hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]{4-[2-(piperidin-1-yl)ethoxy]phenyl}methanone hydrochloride (1:1) |
| Raloxifene HCl |
| [6-Hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl][4-(2-piperidin-1-ylethoxy)phenyl]methanonhydrochlorid |
| 1-[2-(4-{[6-Hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]carbonyl}phenoxy)ethyl]piperidinium chloride |
| [6-Hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]{4-[2-(1-piperidinyl)ethoxy]phenyl}methanone hydrochloride (1:1) |
| Methanone, [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-, hydrochloride (1:1) |
| methanone, [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-, hydrochloride |
| 6-Hydroxy-2-(p-hydroxyphenyl)benzo(b)thien-3-yl-p-(2-piperidinoethoxy)phenyl ketone hydrochloride |
| MFCD01938233 |
| Raloxifene hydrochloride |
| Raloxifene (hydrochloride) |